Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2025 10:57 ET | Source: Block & Leviton LLP

BREAKING: aTyr Pharma Shares Plummet 80%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Block & Leviton is investigating aTyr Pharma after the company announced that its Phase 3 trial for efzofitimod failed to meet its primary endpoint.